Anúncio
Anúncio
SBFM
Sunshine Biopharma Inc.
1.34
USDPatrocinado
-0.03
-2.19%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.27
-0.07
-4.85%
Relatórios de Lucros SBFM
Rácio de surpresa positiva
SBFM separação 1 de 8 últimas estimativas.
13%
Próximo Relatório
Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$10.20M
/-$0.27
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+8.31%
/+42.11%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+6.31%
/-73.00%
Sunshine Biopharma Inc. earnings per share and revenue
On 13 de nov. de 2025, SBFM reported earnings of -0.19 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -43.29% surprise. Revenue reached 9.42 milhão, compared to an expected 11.32 milhão, with a -16.82% difference. The market reacted with a -2.40% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.27 USD, with revenue projected to reach 10.20 milhão USD, implying an aumentar of 42.11% EPS, and aumentar of 8.31% in Revenue from the last quarter.
FAQ
What were Sunshine Biopharma Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Sunshine Biopharma Inc. reported EPS of -$0.19, missing estimates by -43.29%, and revenue of $9.42M, -16.82% below expectations.
How did the market react to Sunshine Biopharma Inc.'s Q3 2025 earnings?
The stock price moved down -2.4%, changed from $1.67 before the earnings release to $1.63 the day after.
When is Sunshine Biopharma Inc. expected to report next?
The next earning report is scheduled for 30 de mar. de 2026.
What are the forecasts for Sunshine Biopharma Inc.'s next earnings report?
Based on 3
analistas, Sunshine Biopharma Inc. is expected to report EPS of -$0.27 and revenue of $10.20M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio